Non-oncologic indications for ALA-PDT

References

• Stern RS, Nichols KT, Väkevä LH, Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med (1997) 336: 1041–5.
   PubMed Web of Science ®Google Scholar
• Stern RS, Lunder EJ, Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis. Arch Dermatol (1998) 134: 1582–5.
   PubMedGoogle Scholar
• Stringer MR, Collins P, Robinson DJ et al, The accumula- tion of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. J Invest Dermatol (1996) 107: 76–81.
   PubMed Web of Science ®Google Scholar
• Hürlimann AF, Panizzon RA, Burg G, Topical photody- namic treatment of skin tumors and dermatoses. Dermatol- ogy (1994) 3: 327.
   Google Scholar
• Weinstein GD, McCullough JL, Jeffes EW et al, Photodynamic therapy of psoriasis with topical delta amino- levulinic acid: a pilot dose ranging study. Photodermatol Photoimmunol Photomed (1994) 10: 92.
   Google Scholar
• Boehncke W-H, Sterry W, Kaufmann R, Treatment of pso- riasis by topical photodynamic therapy with polychromatic light. Lancet (1994) 343: 801.
   PubMed Web of Science ®Google Scholar
• Collins P, Robinson DJ, Stringer MR et al, The variable response of plaque psoriasis after a single treatment with topical 5-aminolevulinic acid photodynamic therapy. Br J Dermatol (1997) 137: 743–9.
   PubMed Web of Science ®Google Scholar
• Robinson DJ, Collins P, Stringer MR et al, Improved response to plaque psoriasis after multiple treatments with topical 5-aminolevulinic acid photodynamic therapy. Acta Derm Venereol (1999) 79: 451–5.
   PubMed Web of Science ®Google Scholar
• Stender IM, Wulf HC, Köbner reaction induced by photo- dynamic therapy using delta-aminolevulinic acid. Acta Derm Venereol (1996) 76: 392–3.
   Google Scholar
• Fitzpatrick TB, Johnson RA, Wolff K et al, Color atlas and synopsis of clinical dermatology, 3rd edition. McGraw Hill, New York: 1997, pp. 766–71.
   Google Scholar
• Fehr MK, Chapman CF, Krasieva T et al, Selective photo- sensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid. Am J Obstet Gynecol (1996) 174: 51–7.
   Google Scholar
• Ross EV, Romero R, Kollias N et al, Selectivity of protopor-phyrin IX fluorescence for condylomata after topical applica- tion of 5-aminolevulinic acid: implications for photodynamic treatment. Br J Dermatol (1997) 137: 736–42.
   PubMed Web of Science ®Google Scholar
• Smetana Z, Malik Z, Orenstein A et al, Treatment of viral infections with 5-aminolevulinic acid and light. Lasers Surg Med (1997) 21: 351–8.
   PubMed Web of Science ®Google Scholar
• Kennedy JC, Pottier RH, Pross DC, Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B (1990) 6: 143–8.
   PubMed Web of Science ®Google Scholar
• Ammann R, Hunziker T, Braathen LR, Topical photo- dynamic therapy in verrucae. A pilot study. Dermatology (1995) 191: 346–7.
   Google Scholar
• Stender IM, Lock-Andersen J, Wulf HC, Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolevulinic acid: a pilot study. Clin Exp Dermatol (1999) 24: 154–9.
   PubMed Web of Science ®Google Scholar
• Stender IM, Na R, Fogh H et al, Photodynamic therapy with 5-aminolevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet (2000) 355: 963–6.
   PubMed Web of Science ®Google Scholar
• Fabbrocini G, Di Constanzo MP, Riccardo AM et al, Photo- dynamic therapy with topical d-aminolevulinic acid for the treatment of plantar warts. J Photochem Photobiol B (2001) 61: 30–4.
   PubMed Web of Science ®Google Scholar
• Frank RG, Bos JD, Photodynamic therapy for condylomata acuminata with local application of 5-aminolevulinic acid. Genitourin Med (1996) 72: 70–1.
   PubMedGoogle Scholar
• Majewski S, Jablonska S, Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol (1995) 131: 1312–18.
   PubMedGoogle Scholar
• Karrer S, Szeimies RM, Abels C et al, Epidermodysplasia verruciformis treated using topical 5-aminolevulinic acid photodynamic therapy. Br J Dermatol (1999) 140: 935–8.
   PubMed Web of Science ®Google Scholar
• Grossman M, Wimberly J, Dwyer P, Photodynamic therapy for hirsutism. Lasers Surg Med Suppl (1995) 7: 44.
   Google Scholar
• Divaris DXG, Kennedy JC, Poittier RH, Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol (1990) 136: 891–7.
   PubMed Web of Science ®Google Scholar
• Dierickx CC, Goldenhersch M, Dwyer P et al, Photo- dynamic therapy for nevus sebaceus with topical d-aminolevulinic acid. Arch Dermatol (1999) 135: 637–40.
   Google Scholar
• Hongcharu W, Taylor CR, Chang Y et al, Topical ALA-pho- todynamic therapy for the treatment of acne vulgaris. J Invest Dermatol (2000) 115: 183–92.
   PubMed Web of Science ®Google Scholar
• Itoh Y, Ninomiya Y, Tajima S, Ishibashi A, Photodynamic therapy of acne vulgaris with topical delta-aminolevulinic acid and incoherent light in Japanese patients. Br J Derma- tol (2001) 144: 575–9.
   PubMed Web of Science ®Google Scholar
• Karrer S, Abels C, Landthaler M, Szeimies RM, Topical pho- todynamic therapy for localized scleroderma. Acta Derm Venereol (2000) 80: 26–7.
   PubMed Web of Science ®Google Scholar
• Seyger MMB, van den Hoogen FHJ, De Boo T, De Jong EMGJ, Reliability of two methods to assess morphea: skin scoring and the use of a durometer. J Am Acad Dermatol (1997) 37: 793–6.
   Google Scholar
• Rook AH, Freundlich B, Jegasothy BV et al, Treatment of systemic sclerosis with extracorporal photochemotherapy. Results of a multicenter trial. Arch Dermatol (1992) 128: 337–46.
   PubMed Web of Science ®Google Scholar
• Hillemanns P, Untch M, Pröve F et al, Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol (1999) 93: 71–4.
   PubMed Web of Science ®Google Scholar